![Te Ling Pang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Te Ling Pang is currently President & Director at UWELL Biopharma, Inc. since 2025.
Formerly, Ms. Pang was Vice President-Research & Development at Vectorite Biomedical, Inc. Education includes undergraduate studies at National Yang Ming University.
| Sociétés | Poste | Début |
|---|---|---|
| UWELL BIOPHARMA, INC. | President | 25/11/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| VECTORITE BIOMEDICAL INC. | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
National Yang Ming University
 National Yang Ming University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vectorite Biomedical, Inc.
 Vectorite Biomedical, Inc. Other TransportationTransportation Develops anti infectious drugs for TIE cell preparation and provides immune cell storage services | Transportation |
UWELL Biopharma, Inc.
 UWELL Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
